Regression of retinal and iris neovascularization after intravitreal bevacizumab (avastin) treatment

被引：240

作者：

Avery, Robert L. ^{[1
]}

机构：

[1] California Retina Consultants & Res Fdn, Santa Barbara, CA 93103 USA

来源：

RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES | 2006年 / 26卷 / 03期

关键词：

bevacizumab; diabetic retinopathy; neovascularization; rubeosis;

D O I：

10.1097/00006982-200603000-00016

中图分类号：

R77 [眼科学];

学科分类号：

100212 ;

摘要：

[No abstract available]

引用

页码：352 / 354

页数：3

共 6 条

[1] Changes in retinal neovascularization after pegaptanib (Macugen) therapy in diabetic individuals
Adamis, AP
Altaweel, M
Bressler, NM
Cunningham, ET
Davis, MD
Goldbaum, M
Gonzales, C
Guyer, DR
Katz, B
Patel, M
[J]. OPHTHALMOLOGY, 2006, 113 (01) : 23 - 28
[2] Inhibition of vascular endothelial growth factor prevents retinal ischemia-associated iris neovascularization in a nonhuman primate
Adamis, AP
Shima, DT
Tolentino, MJ
Gragoudas, ES
Ferrara, N
Folkman, J
DAmore, PA
Miller, JW
[J]. ARCHIVES OF OPHTHALMOLOGY, 1996, 114 (01) : 66 - 71
[3] Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration
Avery, RL
Pieramici, DJ
Rabena, MD
Castellarin, AA
Nasir, MA
Giust, MJ
[J]. OPHTHALMOLOGY, 2006, 113 (03) : 363 - 372
[4] Vascular endothelial growth factor: Basic science and clinical progress
Ferrara, N
[J]. ENDOCRINE REVIEWS, 2004, 25 (04) : 581 - 611
[5] Comparisons of the intraocular tissue distribution, pharmacokinetics, and safety of 125I-labeled full-length and Fab antibodies in rhesus monkeys following lntravitreal administration
Mordenti, J
Cuthbertson, RA
Ferrara, N
Thomsen, K
Berleau, L
Licko, V
Allen, PC
Valverde, CR
Meng, YG
Fei, DTW
Fourre, KM
Ryan, AM
[J]. TOXICOLOGIC PATHOLOGY, 1999, 27 (05) : 536 - 544
[6] Optical coherence tomography findings after an intravitreal injection of bevacizumab (Avastin®) for neovascular age-related macular degeneration
Rosenfeld, PJ
Moshfeghi, AA
Puliafito, CA
[J]. OPHTHALMIC SURGERY LASERS & IMAGING, 2005, 36 (04): : 331 - 335

← 1 →